The most common cancer in the UK is breast cancer and it can occur in both males and females.
Research is driving prevention, treatment and better diagnosis, an example of which is the use of multiplex antibody cocktails such as Menarini’s ‘GCDFP-15 + Mammaglobin’. The combination of the two markers may help to establish the correct interpretation of metastatic breast carcinoma.
This and other multiplex antibody cocktails can help aid pathologists in making faster and more accurate diagnosis as well as requiring less patient tissue and BMS’ time. By coupling these multiplex cocktails with Menarini’s Estrogen Receptor (ER) and Progesterone Receptor (PR) primary antibodies, the pathologist will be equipped, not only to identify a subset of breast carcinomas, but they will also be able to predict how a patient might respond to endocrine therapy.
Menarini are proud to stock a range of these antibodies which aid the diagnosis of Breast cancer and you can read more about them and what they can do on this fact sheet: Key antibodies for the identification of breast cancer
Diagnosis is hugely important because the earlier that you spot the cancer, the more likely the treatment will be effective. There are several signs of breast cancer to watch out for in the breast tissue, extending all the way up to your armpit and upper chest. You need to look out for lumps, swellings, changes in size or shape, colour or texture of the breast tissue – amongst other indicators which can be found at breastcancernow.org or coppafeel.org. You can even sign up to receive their text reminders to ensure you check yourself regularly.